Jobs and People

30 September 2002 00:00  [Source: ICB Americas]

Richard G. Babbitt

Richard G. Babbitt has been elected chairman of the board of directors of Lipid Sciences Inc. Mr. Babbitt has an understanding of the business issues an emerging company faces, as well as experience in successfully commercializing medical products.

David Briscoe

David Briscoe has been appointed vice president of business development and to the board of directors of GenOdys-see SA. Mr. Briscoe has more than 27 years of experience in the pharmaceutical and biotechnology industries.

Angela Cackovich

Angela Cackovich has been appointed market manager for additives in Europe of Rohm and Haas Company. Ms. Cackovich joins the company from Dow Corning Europe.

Steve Cullen

Steve Cullen has been appointed business development manager for performance chemicals and intermediates business organization of Eastman Chemical Com-pany. Mr. Cullen will focus om pharmaceutical and custom synthesis development opportunities.

Mark G. Currie

Mark G. Currie has been appointed vice president of research and development of Microbia Inc. Mr. Currie has more than 12 years of pharmaceutical research experience.

Carol Eicher

Carol Eicher has been named vice president and general manager of the Americas and Europe for the printed wiring board division of Shipley Company LLC. Ms. Eicher joined the division in 2001.

Art Esposito

Art Esposito, marketing director of the performance products group of Church and Dwight Co. Inc., has been elected second vice chairperson of the Chemis-try Council of New Jersey.

Allan Fowler

Allan Fowler, site director of Dow Chemical Company, has been elected treasurer of vice chairperson of the Chemistry Council of New Jersey.

Jean-Marc Giry

Jean-Marc Giry has been appointed vice president of strategic planning and to the board of directors of Gen-Odyssee SA. Mr. Giry has more than 20 years of marketing and business development experience.

David Goodkin

David Goodkin has joined Icos Corp. as vice president of development and chief medical officer. Dr. Goodkin has more than 10 years of experience in drug development.

John Grate

John Grate has been appointed vice president of research and development and chief technology officer of Codexis Inc. Mr. Grate has worked with the company as a member of its industrial advisory board since February 2002.

Hans Hickler

Hans Hickler, group chief information officer of Neptune Orient Lines (NOL), has been named CEO of APL Logistics, a subsidiary of NOL.

Kim David Lamon

Kim David Lamon has been elected to the board of directors of ICN Pharmaceuti-cals Inc. Dr. Lamon has extensive corporate and clinical experience in the pharmaceutical and biotechnology industries.

John E. Lucas

John E. Lucas has joined RxKenetix Inc. as president and CEO. Mr. Lucas brings extensive pharmaceutical and biotechnology experience to the company.

Jean Maral

Jean Maral has been appointed to the board of directors of GenOdyssee SA. He has more than 20 years of experience in the development of therapeutic protein variants. Dr. Maral joined the company in 2001.

Leonard J. Martocci

Leonard J. Martocci has been promoted to director of North American sales, microelectronic materials of Mallinck-rodt Baker Inc. He will spearhead and manage the efforts of the microelectronic sales team. Mr. Martocci has been with the company since 1979.

Maria Matilla

Maria Matilla has become product manager for architectural binders of Rohm and Haas Company. Ms. Matilla joined the company in 1998.

Margie Nemcik-Cruz

Margie Nemcik-Cruz has been appointed vice president of regulatory affairs of Amarin Pharmaceuticals Inc., the USdrug development and marketing subsi-diary of Amarin Corp. PLC. Ms. Nem-cik-Cruz has a track record of progressing innovative new pharmaceutical pro- ducts through the regulatory processes.

Denise O'Leary

Denise O'Leary has been appointed to the board of directors of Chiron Corp. She is a private venture capital investor. Ms. O'Leary serves on the boards of Medtronics Inc., America West Holdings Corp. and Del Monte Foods Company.

Philippe Remes

Philippe Remes has been appointed vice president of investor relations and to the board of the board of directors of Gen-Odyssee SA. Dr. Remes has more than 20 years of experience in the biotechnology and pharmaceutical industries.

Joe Saco

Joe Saco, US manufacturing manager of Infineum USA LP has been elected first vice chairperson of the Chemistry Council of New Jersey.

John Schroeder

John Schroeder, president of Hydro-Globe LLC, has been elected chairman of the Chemistry Council of New Jersey.

Avery Spunt

Avery Spunt has joined the National Association of Boards of Pharmacy as competency assessment director. Mr. Spunt brings 30 years of experience at the University of Illinois at Chicago College of Pharmacy.

James R. Weiss

James R. Weiss has been named infor-mation technology and applications database director of the National Associ-ation of Boards of Pharmacy. Mr. Weiss has more than 20 years of experience in management and consulting.

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly